First Patient Dosed in Syros’ Phase 1 Trial for Ovarian, Other Solid Tumors
News
The first patient has been dosed in a Phase 1 trial assessing Syros Pharmaceuticals‘ investigative therapy SY-1365 in patients with advanced solid tumors, the company announced. The trial will particularly ... Read more